Investigators
Study information
- Research Area: Infectious diseases
- Research type: Cross-sectional
- Start date: Feb 01, 2019
- End date: Dec 30, 2021
Study aim of the objectives
To describe clinical, radiological and social outcomes among multi-drug resistant tuberculosis (MDR-TB) patients after successful completion of standardized second line anti-tuberculosis treatment in Rwanda.
Study setting/Area (Location)
Kibagabaga & Kabutare Hospital
Implementing institution
Rwanda Biomedical Center
Department/Division
TB & NRL
Impact on Policy
Provide direction to tackle social and clinical long term impact of MDR TB